Understanding individuals' subjective experiences of negative symptoms of schizophrenia: A qualitative study.


Journal

The British journal of clinical psychology
ISSN: 0144-6657
Titre abrégé: Br J Clin Psychol
Pays: England
ID NLM: 8105533

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 08 08 2019
revised: 10 03 2020
pubmed: 4 4 2020
medline: 16 1 2021
entrez: 4 4 2020
Statut: ppublish

Résumé

Individuals with a diagnosis of schizophrenia often experience both positive and negative symptoms. Negative symptoms can be disabling and have a serious impact on everyday functioning. Despite the range of clinician-rated measurement tools used to assess negative symptoms, very little is known about how individuals subjectively experience these symptoms. This study sought to examine, using qualitative methods, how people living with a diagnosis of schizophrenia subjectively experience negative symptoms. Qualitative study. Semi-structured interviews were carried out with individuals with a diagnosis of schizophrenia who were experiencing negative symptoms. The sample was recruited from community and inpatient National Health Service mental health settings in the United Kingdom. Interviews were analysed using thematic analysis. Twenty individuals took part. Individuals highlighted the persistent and enduring nature of their negative symptoms. Two central themes were identified: What it is like to experience negative symptoms and where have my negative symptoms come from? Within the first theme, four sub-themes emerged: loss of concentration, loss of motivation, withdrawal, and 'feeling but not feeling'. Within the second theme, four sub-themes emerged related to the causes of negative symptoms: impact of traumatic life events, positive psychotic symptoms, impact of social network, and recreational and prescribed drug use. Individuals, who experience negative symptoms, were able to articulate the persistent and disabling nature of negative symptoms and clearly described factors which they believed contributed to the onset, exacerbation, and amelioration of the experiences. Negative symptoms for people diagnosed with schizophrenia are persistent and enduring and impact an individual's life. There has been little research conducted qualitatively on individuals' subjective experiences of negative symptoms. Individuals who experience negative symptoms attribute these to a number of factors, including adverse life events, recreational and prescribed drug use, an absence of social support, and positive psychotic symptoms. Understanding negative symptoms is important for services, clinicians, and family members, where misattributions made about negative symptoms can lead to such experiences being dismissed.

Identifiants

pubmed: 32242945
doi: 10.1111/bjc.12248
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

319-334

Subventions

Organisme : Medical Research Council Doctoral Training Partnership, Medical Research Council
ID : MR/N013751/1/

Informations de copyright

© 2020 The Authors. British Journal of Clinical Psychology published by John Wiley & Sons Ltd on behalf of British Psychological Society.

Références

Andreasen, N. C. (1982). Negative symptoms in schizophrenia: Definition and reliability. Archives of General Psychiatry, 39, 784-788. https://doi.org/10.1001/archpsyc.1982.04290070025006
Bailey, T., Alvarez-Jimenez, M., Garcia-Sanchez, A. M., Hulbert, C., Barlow, E., & Bendall, S. (2018). Childhood trauma is associated with severity of hallucinations and delusions in psychotic disorders: A systematic review and meta-analysis. Schizophrenia Bulletin, 44, 1111-1112. https://doi.org/10.1093/schbul/sbx161
Barrowclough, C., Haddock, G., Wykes, T., Beardmore, R., Conrod, D., Craig, T., … Moring, J. (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: Randomised controlled trial. British Medical Journal, 341, c6325. https://doi.org/10.1136/bmj.c6325
Beichtman, J. H., Zucker, K. J., Hood, J. E., DaCosta, G. A., Akman, D., & Cassavia, E. (1992). A review of the long-term effects of child sexual abuse. Child Abuse and Neglect, 16, 101-118. https://doi.org/10.1016/0145-2134(92)90011-f
Bleuler, E. (1911). Dementia Praecox oder Gruppe der Schizophrenien. Leipzig, Germany: F. Deuticke. https://doi.org/10.1055/s-0031-1295586
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 77-101. https://doi.org/10.1191/1478088706qp063oa
Brooks, H., Rushton, K., Walker, S., Lovell, K., & Rogers, A. (2016). Ontological security and connectivity provided by pets: A study in the self-management of the everyday lives of people diagnosed with a long-term mental health condition. BMC Pyschiatry, 16, 409. https://doi.org/10.1136/bmj.c6325
Cella, M., Preti, A., Edwards, C., Dow, T., & Wykes, T. (2016). Cognitive remediation for negative symptoms of schizophrenia: A network meta-analysis. Clinical Psychology Review, 52, 43-51. https://doi.org/10.1016/j.cpr.2016.11.009
Cohen, J. A., Deblinger, E., & Mannarino, A. (2004). Trauma-focused cognitive-behavioral therapy for sexually abused children. Psychiatric Times, 21, 109-121.
Faulkner, A., Carr, S., Gould, D., Khisa, C., Hafford-Letchfield, T., Cohen, R., … Holley, J. (2019). Dignity and respect’: An example of service user leadership and co-production in mental health research. Health Expectations, 1-10. https://doi.org/10.1111/hex.12963
Ferhava, G., Foussias, G., Agid, O., & Remington, G. (2014). Impact of primary negative symptoms on functional outcomes in schizophrenia. European Psychiatry, 29, 449-455. https://doi.org/10.1016/j.eurpsy.2014.01.007
Gallagher, B., & Jones, B. J. (2013). Childhood stressors and symptoms of schizophrenia. Clinical Schizophrenia and Related Psychoses, 7, 124-130. https://doi.org/10.3371/csrp.gajo.020113
Gallagher, B., Jones, B. J., & Pardes, M. (2016). Stressful life events, social class and symptoms of schizophrenia. Clinical Schizophrenia and Related Psychoses, 10, 101-108. https://doi.org/10.3371/csrp.gajo.112013
Gee, B., Hodgekins, J., Lavis, A., Notley, C., Birchwood, M., Everard, L., … Marshall, M. (2018). Lived experiences of negative symptoms in first-episode psychosis: A qualitative secondary analysis. Early Intervention in Psychiatry, 13, 773-779. https://doi.org/10.1111/eip.12558
Harvey, R. C., James, A. C., & Shields, G. E. (2016). A systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia. CNS Drugs, 30, 27-39. https://doi.org/10.1007/s40263-015-0308-1
Horan, W. P., Brown, S. A., & Blanchard, J. J. (2007). Social anhedonia and schizotypy: The contribution of individual differences in affective traits, stress, and coping. Psychiatry Research, 149, 147-156. https://doi.org/10.1016/j.psychres.2006.06.002
Johnson, D. P., Penn, D. L., Fredrickson, B. L., Meyer, P. S., Kring, A. M., & Brantley, M. (2009). Loving-kindness meditation to enhance recovery from negative symptoms of schizophrenia. Journal of Clinical Phsychology, 65, 499-509. https://doi.org/10.1002/jclp.20591
Kalant, O. J. (1972). Report of the Indian Hemp Drugs Commission, 1893-94: A critical review. International Journal of the Addictions, 7, 77-96. https://doi.org/10.3109/10826087209026763
Kay, S. R., Fiszbein, A., & Opfer, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261. https://doi.org/10.1093/schbul/13.2.261
Kraepelin, E., Barclay, R. M., & Robertson, G. M. (1919). Dementia praecox and paraphrenia. Edinburgh, UK: E & S Livingstone.
Kraus, M., Zhu, Y., Huhn, M., Scneider-Thoma, J., Bighelli, I., Nikolakopoulou, A., & Leucht, S. (2018). Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: A systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 268, 625-639. https://doi.org/10.1007/s00406-018-0869-3
Kring, A. M., Gur, R. E., Blanchard, J. J., Joran, W. P., & Reise, S. P. (2013). The clinical assessment interview for negative symptoms (CAINS): Final development and validation. American Journal of Psychiatry, 170, 165-172. https://doi.org/10.1176/appi.ajp.2012.12010109
Lane, S. D., Cherek, D. R., Pietras, C. J., & Steinberg, J. L. (2005). Performance of heavy marijuana-smoking adolescents on a laboratory measure of motivation. Addict Behavior, 30, 815-828. https://doi.org/10.1016/j.addbeh.2004.08.026
Miller, D. D. (2004). Atypical antipsychotics: Sleep, sedation, and efficacy. Primary Care Companion to the Journal of Clinical Psychiatry, 6(Suppl 2), 3.
Norris, J. M., Nowell, L. S., White, D. E., & Moules, N. J. (2017). Thematic analysis: Striving to meet the trustworthiness criteria. International Journal of Qualitative Methods, 16(1), 1609406917733847.
Pacheco-Colón, I., Ramirez, A. R., & Gonzalez, R. (2019). Effects of adolescent cannabis use on motivation and depression: A systematic review. Current Addiction Reports, 6, 532-546. https://doi.org/10.1007/s40429-019-00274-y
Read, J., van Os, J., Morrison, A. P., & Ross, C. A. (2005). Childhood trauma, psychosis and schizophrenia: A literature review with theoretical and clinical implications. Acta Psychiatrica Scandinavica, 112, 330-350. https://doi.org/10.1111/j.1600-0447.2005.00634.x
Remington, G., Foussias, G., Ferhava, G., Agid, O., Takeuchi, H., Lee, J., & Hahn, M. (2016). Treating negative symptoms in schizophrenia: An update. Current Treatment Options in Psychiatry, 3, 133-150. https://doi.org/10.1007/s40501-016-0075-8
Rohricht, F., & Priebe, S. (2006). Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: A randomized controlled trial. Psychological Medicine, 36, 669-678. https://doi.org/10.1017/s0033291706007161
Selten, J.-P., Hajo, B. P., Gernaat, M. D., Nolen, W. A., Wiermsa, D., & van den Bosch, R. J. (1998). Experience of negative symptoms: Comparison of schizophrenic patients to patients with a depressive disorder and to normal subjects. American Journal of Psychiatry, 155, 350-354. https://doi.org/10.1176/ajp.155.3.350
Selten, J. P., Silben, N. E., van den Bosch, R. J., Omloo-Visser, J., & Warmerdam, H. (1993). The subjective experience of negative symptoms: A self-rating scale. Comprehensive Psychiatry, 34, https://doi.org/10.1016/0010-440x(93)90047-8
Stahl, S. M., & Buckley, P. F. (2007). Negative symptoms of schizophrenia: A problem that will not go away. Acta Psychiatrica Scandinavica, 115, 4-11. https://doi.org/10.1111/j.1600-0447.2006.00947.x
Stampfer, H. G. (1990). Negative symptoms: A cumulative trauma stress disorder? Australian and New Zealand Journal of Psychiatry, 24, 516-528. https://doi.org/10.3109/00048679009062908
Staring, A. B., ter Huurne, M. A., & van der Gaag, M. (2013). Cognitive behavioral therapy for negative symptoms (CBT-n) in psychotic disorders: A pilot study. Journal of Behaviour Therapy and Experimental Psychiatry, 44, 300-306. https://doi.org/10.1016/j.jbtep.2013.01.004
Tanskanen, S., Morant, N., Hinton, M., Lloyd-Evans, B., Crosby, M., Killaspy, H., … Johnson, S. (2011). Service user and carer experiences of seeking help for a first episode of psychosis: A UK qualitative study. BMC Psychiatry, 11(1), 157. https://doi.org/10.1186/1471-244X-11-157
Varese, F., Barkus, E., & Bentall, R. P. (2012). Dissociation mediates the relationship between childhood trauma and hallucination-proneness. Psychological Medicine, 42, 1025-1036. https://doi.org/10.1017/S0033291711001826
Willig, C. (2008). Introducing qualitative research in psychology. Berkshire, UK: Open University Press.
Zubin, J., & Spring, B. (1977). Vulnerability: A new view of schizophrenia. Journal of Abnormal Psychology, 86, 103. https://doi.org/10.1037/0021-843X.86.2.103

Auteurs

Isabelle Butcher (I)

Division of Psychology and Mental Health, School of Health Sciences, University of Manchester, UK.
Manchester Academic Health Sciences Centre, Manchester, UK.

Katherine Berry (K)

Division of Psychology and Mental Health, School of Health Sciences, University of Manchester, UK.
Manchester Academic Health Sciences Centre, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Gillian Haddock (G)

Division of Psychology and Mental Health, School of Health Sciences, University of Manchester, UK.
Manchester Academic Health Sciences Centre, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH